Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
25.07
-1.18 (-4.51%)
Aug 28, 2026, 11:36 AM EDT - Market open
Seaport Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Seaport Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $37. The average 1-year stock price forecast is 47.62% higher than the current stock price, while the lowest is $30 (+19.69%) and the highest is $50 (+99.48%).
Price Target: $37 (+47.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Seaport Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Initiates $32 | Buy | Initiates | $32 | +27.67% | Aug 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +99.48% | Aug 20, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $30 | Buy | Maintains | $30 | +19.69% | Aug 13, 2026 |
| Citi | Citi | Buy Maintains $35 | Buy | Maintains | $35 | +39.64% | Aug 4, 2026 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 7, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.90
EPS Next Year
-2.57
from -5.90
EPS and Forward PE are based on non-GAAP adjusted numbers.